|
Information For:
|
Tazobactam: Notice of Intent to ReviseFebruary 29, 2008The Monograph Development: Antibiotics Expert Committee has proposed a revision to the Tazobactam monograph. Comments were received from the sponsor that the Standard preparation, Assay preparation and System suitability solution used in the Assay should be made in the Mobile phase rather than in water. The preparation instructions for these solutions have been corrected and will be published in the Pharmacopeial Forum. It is proposed to publish the revision proposal in Pharmacopeial Forum 34(2) [March – April 2008]. In the absence of any adverse comments, this revision will become official in the First Supplement to USP 32–NF 27, with an official date of August 1, 2009. Should you have any questions, please contact Ahalya Wise, MS, Scientist and Liaison to the Monograph Development: Antibiotics Expert Committee (301–816–8161) or . What's New![]() USP-NF Recall Update: Third Public Notice (03/05/10)
USP is RecallingUSP 33–NF 28 Due to Errors. (01/26/10)
PF 36(2), March-April 2010: IRAs and Errata (03/01/10) February Revision Bulletins (02/26/10) Protamine Monographs: Notice of Intent to Revise (02/26/10) New Draft Pending Standard for the month of February (02/26/10) PF 36(2), March-April 2010: Highlights (02/22/10) Calculation Tool for the Performance Verification Test (PVT) of Dissolution Assemblies (02/22/10) Performance of Equipment to Test Dissolution of Medications Further Assured (02/09/10) New Official Text (01/29/10) Related Resources |
||||||||||||||||||||||||||||
Copyright © 2010 The United States Pharmacopeial Convention
|
|||||||||||||||||||||||||||||